封面
市场调查报告书
商品编码
1464696

眼科用粘性弹性设备(OVD)的全球市场 - 市场规模(各市场区隔),占有率,法规,偿付,治疗,预测(~2033年)

Ophthalmic Viscoelastic Devices (OVD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

本报告提供全球眼科用粘性弹性设备(OVD)市场相关调查分析,提供各市场区隔的市场规模,市场趋势,竞争情形,COVID-19影响等资讯。

市场模式的主要内容如下列。

眼科用粘性弹性设备(OVD)已上市以及不断变化的竞争格局

  • 主要的产业趋势的考察
  • 眼科用粘性弹性设备(OVD)市场区隔的年度收益与市场预测(2015年~2033年)
  • 有关各市场区隔的整体治疗数,台数,平均销售价格,市场金额的详细的资料

世界,地区,国家层级的市场固有的考察

  • 各地区分类的全球趋势之定性市场固有资讯与各国考察
  • 眼科用粘性弹性设备(OVD)市场SWOT分析
  • 眼科用粘性弹性设备(OVD)市场竞争动态的考察和趋势

透过对医疗保健系统的真正整体了解来加速市场了解。市场进入部分还提供有关报销政策和监管环境的信息,使您能够更深入地研究市场动态。

  • 各国医疗制度概要
  • 各国偿付政策
  • 各国医疗技术相关法规形势

对象企业

  • Carl Zeiss Meditec AG
  • Bausch & Lomb Inc
  • Johnson & Johnson Vision Care Inc
  • Alcon Inc
  • Rayner Intraocular Lenses Ltd
  • Aurolab
  • 其他
简介目录
Product Code: GDME721MM

Ophthalmic Viscoelastic Devices (OVD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Ophthalmic Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Ophthalmic Viscoelastic Devices (OVD) market for the year 2020 and beyond. Ophthalmic viscoelastic devices, also known as OVDs, are devices used during intraocular surgery and are primary composed of sodium hyaluronate, chondroitin sulphate, or hydroxypropyl methylcellulose. These devices protect delicate ocular structures and reduce post operational complications such as corneal edema.

OVDs help maintain pressure in the anterior chamber of the eyes and prevent iris prolapse by maintaining compartmentalization of the eyes. The use of these devices significantly reduces patient recovery times. They are often used in cataract surgeries, including extracapsular and phacoemulsification surgeries.

Ophthalmic Viscoelastic Devices (OVD) have a long history of use in the US and European markets and are well established in emerging markets such as APAC and South America.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Ophthalmic Viscoelastic Devices (OVD) and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Ophthalmic Viscoelastic Devices (OVD) market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Ophthalmic Viscoelastic Devices (OVD) market.
  • Competitive dynamics insights and trends provided for Ophthalmic Viscoelastic Devices (OVD) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Carl Zeiss Meditec AG, Bausch & Lomb Inc, Johnson & Johnson Vision Care Inc, Alcon Inc, Rayner Intraocular Lenses Ltd, Aurolab, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Ophthalmic Viscoelastic Devices (OVD) marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Ophthalmic Viscoelastic Devices (OVD).
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Ophthalmic Viscoelastic Devices (OVD).
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Ophthalmic Viscoelastic Devices (OVD) market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Ophthalmic Viscoelastic Devices (OVD) market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.